Author name: Leonardo Arias

The acquisition, which will give RadNet a new professional services unit, is expected to help hospitals solve challenges with radiology coverage.

The FDA has outlined a process for allowing a single application to cover multiple variants of a gene therapy. At the same time, the Centers for Medicare & Medicaid Services has revealed plans to expand the Cell and Gene Therapy Access Model to increase patient access to these products.

The hospital operator has lost about $950 million in pretax earnings this year as more patients leave the exchanges. Uncompensated care and delays in elective surgeries from the trend are hitting hospitals’ earnings.

It’s a “contrarian move” for the company as much of the industry remains wary of agentic AI, according to Zocdoc CEO Dr. Oliver Kharraz.  

With pressure on GSK’s vaccine business, analysts predict the U.K. pharma will face challenges as it prepares for the loss of exclusivity on a key product.

Growth portfolio products like Leqembi and Spinraza helped drive Biogen to $2.8 billion in revenue for the third quarter.

Astellas Pharma could secure the exclusive global rights to Audax Biosciences’ DAX-044, an antibody-cytokine fusion therapy that activates the immune system in the vicinity of the tumor.

Eli Lilly’s next-gen weight loss drug retatrutide soundly beat Novo’s approved medicine Ozempic in weight loss and blood sugar reduction, padding the case for a regulatory application that’s expected in the first quarter of 2027.

Merck stole the show at the European Society for Medical Oncology (ESMO) annual conference, with new data on its Moderna-partnered personalized cancer vaccine leaking prior to the presentation and antibody-drug conjugate sac-TMT making a splash in endometrial cancer; Bristol Myers Squibb revealed the death of a patient with multiple sclerosis in an early-stage trial of

Durante milenios, la humanidad asumió una frontera infranqueable entre el mundo de lo inanimado y el dominio de los seres vivos. Se creía firmemente que los compuestos que formaban parte de la materia viva albergaban una fuerza invisible, etérea y exclusiva de la biología …